Topics of the NCT Trial Center´s newsletter in June 2017 are:

• REMOTUX, a phase II study with cetuximab in patients with metastatic colorectal cancer, successfully completed
• Sickle-cell disease registry of the GPOH
• Ethics and Laws are in Flux – News with reference to laws and regulations

Download (PDF-File): Newsletter June 2017 | English»
Download (PDF-File): Newsletter June 2017 | German»